Home › Neurologic Diseases › NCT01524276
Product Surveillance Registry
Medtronic Product Surveillance Registry
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment Exclusion Criteria: * Patient who is, or will be, inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
About the study
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Sponsor: Medtronic · Participants: 100,000 · Started: 2012-01
Contact the study team
Official record on ClinicalTrials.gov — NCT01524276
Locations in the U.S.
Conditions
- Neurologic Diseases
- Cardiovascular Disease
- Digestive Diseases
- Brain Aneurysm
- Renal Insufficiency
- Coronary Artery Disease
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.